Quality Indicator 2018［医療の質］を測り改善する

出版社： インターメディカ
著者：
発行日： 2018-12-20
分野： 医学一般  >  病院管理学
ISBN： 9784899963783
電子書籍版： 2018-12-20 （初版第1刷）
書籍・雑誌
≪全国送料無料でお届け≫
品切れ

3,300 円(税込)

電子書籍
章別単位での購入はできません
ブラウザ、アプリ閲覧

3,300 円(税込)

購入する
特記事項：

商品紹介

どうすれば質の高い医療を提供できるか。聖路加国際病院の2004年から2017年までの14年間にわたる診療の質指標（QI）の経年変化、PDCAサイクルを回し続けてきた改善の試みを紹介する。聖路加国際病院の14年に渡る改善活動を収載した2018年版が登場!!「医療の質」改善を目指す病院が急増する今、手引きとなる一冊です。病院・医療法人経営者・管理者など、病院経営・管理に携わる方々に必読の書。

目次

  • 第1章　医療の質とEBM、Quality Indicator
    第2章　Quality Indicator選定基準、質改善と患者安全のための方略
    第3章　病院全体
    第4章　報告・記録
    第5章　教育
    第6章　看護
    第7章　薬剤
    第8章　手術・処置
    第9章　生活習慣
    第10章　脳・神経
    第11章　心血管
    第12章　慢性腎臓病
    第13章　眼・耳鼻咽喉
    第14章　救急
    第15章　腫瘍
    第16章　感染管理

この書籍の参考文献

参考文献のリンクは、リンク先の都合等により正しく表示されない場合がありますので、あらかじめご了承下さい。

本参考文献は電子書籍掲載内容を元にしております。

第1章 医療の質とEBM、Quality Indicator

P.15 掲載の参考文献
1) Donabedian A : Evaluating the quality of medical care. Milbank Memorial Fund Quarterly. 1966 ; 44 : 166-206.
 
2) Fletcher RH, et al. : Clinical Epidemiology : The Essentials. 4th ed. Lippincott Williams & Wilkins, Baltimore, 2005 (福井次矢 (監訳). メディカル・サイエンス・インターナショナル, 2006).
 
P.16 掲載の参考文献
3) Lohr KN (ed). Medicine : A strategy for quality assurance. Vols I and II. Washington DC : National Academy Press, 1990.
 
P.18 掲載の参考文献
4) Medical Milestones : Celebrating key advances since 1840. British Medical Journal. 2007 ; 334 : s10.
 
P.20 掲載の参考文献
5) Mainz J : Defining and classifying clinical indicators for quality improvement. Int J Qual Health Care. 2003 ; 15 : 523-530.
PubMed
6) Ader M, et al. : Quality Indicators for health promotion programmes. Health promotion International. 2001 ; 16 : 187-195.
PubMed
7) Guthrie B, et al. : Tackling therapeutic inertia : role of treatment data in quality indicators. BMJ. 2007 ; 335 : 542-544.
PubMed
8) Campbell SM, et al. : Improvements in quality of clinical care in English general practice 1998-2003 : longitudinal observational study. BMJ. 2005 ; 331 : 1121.
PubMed
9) Rollow W, et al. : Assessment of the Medicare quality improvement organization program. Ann Intern Med. 2006 ; 145 : 342-353.
PubMed
P.23 掲載の参考文献
10) 2009年度厚生労働省科学研究費補助金 (地域医療基盤開発推進研究事業) 「医療の質向上に資するアウトカム評価に関する研究」 (研究代表者 : 福井次矢), 2010年5月.
 

第2章 Quality Indicator選定基準、質改善と患者安全のための方略

P.36 掲載の参考文献
1) National Quality measures Clearinghouse. Selecting Quality Measures. https://www.qualitymeasures.ahrq.gov/help-and-about/quality-measuretutorials/selecting-quality-measures (2018. 07. 15 available)
 
2) National Quality measures Clearinghouse. Use of Quality Measures.
 
3) National Quality measures Clearinghouse. Validity of Clinical Quality Measures.
 
4) National Quality measures Clearinghouse. Desirable Attributes of a Quality Measures.
 
5) Hughes RG : Tools and Strategies for Quality Improvement and Patient Safety. In : Hughes RG, editor. Patient Safety and Quality : An Evidence-Based Handbook for Nurses. Rockville (MD) : Agency for Healthcare Research and Quality (US) ; 2008. Chapter 44.
 
6) Lynn J, Baily MA, Bottrell M, Jennings B, Levine RJ, Davidoff F, Casarett D, Corrigan J, Fox E, Wynia MK, Agich GJ, O'Kane M, Speroff T, Schyve P, Batalden P, Tunis S, Berlinger N, Cronenwett L, Fitzmaurice JM, Dubler NN, James B : The ethics of using quality improvement methods in health care. Ann Intern Med. 2007 ; 146 (9) : 666-673.
PubMed
7) Shojania KG, McDonald KM, Wachter RM, Owens DK, editors : Closing the Quality Gap : A Critical Analysis of Quality Improvement Strategies (Vol. 1 : Series Overview and Methodology). Rockville (MD) : Agency for Healthcare Research and Quality (US) ; 2004.
 
8) Wyatt J, Spiegelhalter D : Field trials of medical decision-aids : potential problems and solutions. Proc Annu Symp Comput Appl Med Care. 1991 : 3-7.
PubMed
9) Berner ES : Clinical decision support systems : State of the Art. AHRQ Publication No. 09-0069-EF. Rockville, Maryland : Agency for Healthcare Research and Quality. June 2009.
 
10) Lobach D, Sanders GD, Bright TJ, et al. : Enabling health care decisionmaking through clinical decision support and knowledge management. Evid Rep Technol Assess (Full Rep). 2012 ; (203) : 1-784.
PubMed
11) 公益社団法人日本産科婦人科学会, 公益社団法人日本産婦人科医会編集・監修. 産婦人科診療ガイドライン 産科編 2014. 公益社団法人日本産科婦人科学会事務局.
 
12) 嶋田元, 山川真紀子, 春田潤一, 福井次矢 : 電子カルテシステム内に構築した臨床決断支援システム. 医療情報学. 2013 ; 33 (2) 69-77.
 
P.39 掲載の参考文献
1) N ational Quality Forum. https://www.qualityforum.org/Home.aspx (2018. 08. 16 available)
 
2) The Joint Commission. https://www.jointcommission.org/ (2018. 08. 16 available)
 
3) AHRQ : Agency for Healthcare Research and Quality. https://www.ahrq.gov/gam/index.html (2018. 08. 16 available)
 
4) The Joint Commission : America's Hospitals : Improving Quality and Safety. Annual Report 2017. http://www.new-media-release.com/jointcommission/2017_annual_report/2017-annual-report.pdf (2018. 08. 15 available)
 

第3章 病院全体

P.44 掲載の参考文献
1) 上原鳴夫, 飯塚悦功, 他 : 医療の質マネジメントシステム-医療機関におけるISO 9001の活用 (Management System ISO SERIES). 日本規格協会, 2003.
 
2) 井部俊子, 中西睦子監修 : 看護管理学習テキスト 第2版 看護経営・経済論. 日本看護協会出版会, 2011.
 
3) EB NURSING編集委員・同編集部 : 看護データバンク-医療・看護の今とコトバがわかる. EB Nursing Vol.10 増刊1号. 中山書店, 2010.
 
4) 厚生統計協会編 : 厚生の指標 増刊 国民衛生の動向 2011/2012. 厚生統計協会, 2010.
 
5) 平成29年 病院運営実態分析調査の概要 (平成29年6月調査). 一般社団法人 全国公私病院連盟 一般社団法人 日本病院会 (平成30年3月1日) https://www.hospital.or.jp/pdf/06_20180301_01.pdf (2018. 07. 10 available)
 
P.46 掲載の参考文献
1) 田島誠一, 高橋淑郎 : 病院管理. 建帛社, 2012.
 
2) 第1回特定機能病院及び地域医療支援病院のあり方に関する検討会資料. http://www.mhlw.go.jp/stf/shingi/2r985200000253pd-att/2r985200000253tc.pdf (2017. 10. 19 available)
 
P.48 掲載の参考文献
1) Britton J, et al. : Tobacco smoking, harm reduction, and nicotine product regulation. Lancet 2008 ; 371 : 441-445.
PubMed
2) Oberg M, et al. : Worldwide burden of disease from exposure to second-hand smoke : a retrospective analysis of data from 192 countries. Lancet 2011 ; 377 (9760) : 139-146.
PubMed
3) 厚生労働省 : 平成28年国民健康・栄養調査報告 (第3部 第4章 飲酒・喫煙に関する状況).
 
P.51 掲載の参考文献
1) 平成29年病院運営実態分析調査の概要 (平成29年6月調査) : 一般社団法人 全国公私病院連盟・一般社団法人 日本病院会 (平成30年3月1日). https://www.hospital.or.jp/pdf/06_20180301_01.pdf (2018. 07. 10 available)
 
P.56 掲載の参考文献
HCAHPS公式サイト https://www.hcahpsonline.org/ (2018. 10. 12 available)
 
P.57 掲載の参考文献
1) 一般社団法人 日本病院会 : 2016年度 QIプロジェクト結果報告. https://www.hospital.or.jp/pdf/06_20171213_01.pdf (2018. 05. 31 available)
 

第4章 報告・記録

P.63 掲載の参考文献
1) The Australian Council on Healthcare Standards (ACHS). AUSTRALASIAN CLINICAL INDICATOR REPORT 15th Edition 2006-2013. http://www.achs.org.au/media/88679/clinical_indicator_report_2006_2013.pdf (2017. 06. 24 available)
 
P.64 掲載の参考文献
1) The Australian Council on Healthcare Standards (ACHS). AUSTRALASIAN CLINICAL INDICATOR REPORT 15th Edition 2006-2013. http://www.achs.org.au/media/88679/clinical_indicator_report_2006_2013.pdf (2017. 06. 24 available)
 
P.67 掲載の参考文献
1) Graat ME, Kroner A, Spronk PE, Korevaar JC, Stoker J, Vroom MB, Schultz MJ : Elimination of daily routine chest radiographs in a mixed medicalsurgical intensive care unit. Intensive Care Med. 2007 ; 33 (4) : 639-644.
 
2) Oba Y, Zaza T : Abandoning daily routine chest radiography in the intensive care unit : meta-analysis. Radiology. 2010 ; 255 (2) : 386-395.
PubMed
3) Amorosa JK, Bramwit MP, Mohammed TL, Reddy GP, Brown K, Dyer DS, Ginsburg ME, Heitkamp DE, Jeudy J, Kirsch J, MacMahon H, Ravenel JG, Saleh AG, Shah RD, Expert Panel on Thoracic Imaging : ACR Appropriateness Criteria(R) routine chest radiographs in ICU patients. American College of Radiology (ACR) ; p6. 2011.
 
P.69 掲載の参考文献
1) T he Australian Council on Healthcare Standards : ACHS Australasian Clinical Indicator Report : 2005-2012 Determining the Potential to Improve Quality of Care : 14th Edition. http://www.achs.org.au/media/76497/pathologygc.pdf (2014. 03. 25 available)
 
P.71 掲載の参考文献
1) Australasian Clinical Indicator Report 18th Edition 2009-2016. https://www.achs.org.au/media/131898/2017acir_web_version.1.pdf (2018. 07. 12 available)
 
P.72 掲載の参考文献
1) Matsumoto Y et al. : Evaluated Laboratory Information Technology for Quality Manager Our Clinical Laboratory.The 6th Cherry Blossom Symposium. International Conference of Clinical Laboratory Automation and Robotics, Kobe, Japan. April 18-19, P.79, 2008.
 
2) 佐々木良子, 他 : 検査室精度管理の定量評価について. 臨床病理. 54 : 168, 2006.
Medical*Online
3) S hikano H et al. : Evaluation of Renovated Laboratory Information System and Laboratory Automation System for Quality Management of Clinical Laboratory. The 10th Cherry Blossom Symposium-international Conference of Clinical Laboratory Automation, Seoul, Korea, April 20-22, P.53, 2016.
 
4) 田篠絵理香, 他 : 当院検体検査室の全面改装およびシステム更新による業務効果の評価-JCI認証の過程を含め-. 臨床病理. 66 : 24, 2018.
Medical*Online

第5章 教育

P.79 掲載の参考文献
1) 医師臨床研修マッチング協議会 平成29年度 都道府県毎第一希望マッチ者数. http://www.jrmp.jp/rol/2017rol.pdf (2018. 05. 31 available)
 
2) 一般社団法人 日本専門医機構 http://www.japan-senmon-i.jp/ (2018. 05. 31 available)
 
P.80 掲載の参考文献
1) 日本看護協会ホームページ. http://www.nurse.or.jp/ (2018. 08. 07 available)
 
2) 日本看護協会編 : 平成29年版 看護白書. 日本看護協会出版会, 2017.
 
3) 厚生労働統計協会編 : 厚生の指標 増刊 国民衛生の動向 2017/2018. 厚生労働統計協会, 2017.
 
P.84 掲載の参考文献
1) 厚生労働統計協会編 : 厚生の指標 増刊 国民衛生の動向 2017/2018. 厚生労働統計協会, 2017.
 
2) 日本看護系大学協議会. http://www.janpu.or.jp
 
3) 日本看護協会編 : 平成29年版 看護白書. 日本看護協会出版会, 2017.
 
4) U. S. Department of Health and Human Services Health Resources and Ser vices Administration ; Findings from the 2008 National Sample Survey of Registered Nurses : The Registered Nurse Population. http://thefutureofnursing.org/sites/default/files/RN%20Nurse%20Population.pdf (2014. 03. 25 available)
 

第6章 看護

P.88 掲載の参考文献
1) 「看護ケアの質の評価基準に関する研究」 : 1993年文部科学研究, 主任研究者片田範子.
 
2) American Nurses Credentialing Center : Magnet Recognition Program, 2005.
 
3) The Australian Council on Healthcare Standards : ACHS Australasian Clinical Indicator Report : 2001-2008 Determining the Potential to Improve Quality of Care : 10th Edition. http://www.achs.org.au/pdf/temp/Australasian_Clinical_Indicator_Report_200108_10thEdition.pdf (2011. 04. 25 available)
 
4) 一般社団法人 日本病院会 : 2016年度 QIプロジェクト (QI推進事業) 結果報告. https://www.hospital.or.jp/pdf/06_20171213_01.pdf (2018. 07. 10 available)
 
P.89 掲載の参考文献
5) The Joint Commission ; The Implementation Guide for the NQF Endorsed Nursing-Sensitive Care Measure Set 2009, version 2.0. http://www.jointcommission.org/assets/1/6/NSC%20Manual.pdf (2017. 06. 24 available)
 
6) European Pressure Ulcer Advisory Panel and National Pressure Ulcer Advisory Panel ; Pressure Ulcer Prevention : Quick Reference Guide. http://www.npuap.org/Final_Quick_Prevention_for_web_2010.pdf (2017. 06. 24 available)
 
7) 日本褥瘡学会編 : 褥瘡予防・管理ガイドライン 第2版. 照林社, 2009.
 
P.91 掲載の参考文献
1) 日本褥瘡学会編 : 褥瘡予防・管理ガイドライン 第2版. 照林社, 2009.
 
P.92 掲載の参考文献
1) 迫田綾子 : 摂食・嚥下障害患者への口腔ケア. 臨床看護. 2009 ; 35 (4) 518-527.
 
2) 大西徹郎, 他 : 口腔ケアのチームアプローチとそのシステム. 看護技術. 2008 ; 54 (14).
 
3) 日本医科大学付属病院 木野毅彦, 他監修 : 口腔ケアの達人になる! . 看護ジャーナル. 2011 ; 28-41.
 
4) ヴァージニア・ヘンダーソン著 ; 湯槇ます・児玉香津子訳 : 看護の基本となるもの. 日本看護協会出版会, 2006.
 
5) Andersson P, Hallberg IR, Renvert S : Inter-rater reliability of an oral assessment guide for elderly patients residing in a rehabilitation ward. Spec Care Dentist. 2002 ; 22 (5) : 181-186.
 
6) 高松由紀, 宇都宮明美 : 兵庫医科大学病院VAP予防の創意工夫. 重症集中ケア. 2010 ; 8 (5) : 95-102.
 
P.96 掲載の参考文献
1) Inouye SK, Westendorp RG, Saczynski JS : Delirium in elderly people. Lancet. 2014 ; 383 (9920) : 911-922.
PubMed
2) 保坂隆監修 : 在院日数短縮化をめざして <QOL向上のために> (青木孝之他 : せん妄と在院日数). 星和書店, 2002. P32-35.
 
3) Inouye SK : The dilemma of delirium : clinical and research controversies regarding diagnosis and evaluation of delirium in hospitalized elderly medical patients. Am J Med. 1994 ; 97 (3) : 278-288.
PubMed
4) de la Cruz M, Fan J, Yennu S, et al. : The frequency of missed delirium in patients referred to palliative care in a comprehensive cancer center. Support Care Cancer. 2015 ; 23 (8) : 2427-2433.
 
5) National Clinical Guideline Centre (UK) : Delirium : Diagnosis, Prevention and Management [Internet]. National Institute for Health and Clinical Excellence, London. 2010.
PubMed
6) 日本総合病院精神医学会せん妄指針改訂班編 : せん妄の臨床指針[せん妄の治療指針 第2版]. 星和書店, 2015.
 
P.100 掲載の参考文献
1) 厚生労働科学研究費補助金事業 (医療安全・医療技術評価総合研究事業) 平成16-18年度「医療安全のための教材と教育方法の開発に関する研究」班研究報告書 別冊「転倒・転落対策のガイドライン」 (主任研究者 : 上原鳴夫).
 
2) Healey F, Scobie S, Glampson B, Pryce A, Joule N, Willmott M : Slips, trips and falls in hospital. London : NHS 2007 ; 1.
 
3) Montalvo I : The National Database of Nursing Quality Indicators TM (NDNQI(R)). OJIN : The Online Journal of Issues in Nursing 2007 ; 12.
 
4) 一般社団法人 日本病院会 : 2016年度 QIプロジェクト (QI推進事業) 結果報告. https://www.hospital.or.jp/pdf/06_20171213_01.pdf (2018. 07. 10 available)
 
P.103 掲載の参考文献
1) Healey F, Scobie S, Glampson B, Pryce A, Joule N, Willmott M : Slips, trips and falls in hospital. London : NHS. 2007 ; 1.
 

第7章 薬剤

P.108 掲載の参考文献
1) kirigaya D, Nakayama T, Ishizaki T, Ikeda S, Satoh T : Management and treatment of osteoporosis in patients receiving long-term glucocorticoid treatment : current status of adherence to clinical guidelines and related factors. Intern Med. 2011 ; 50 (22) : 2793-2800.
PubMed
2) Majumdar SR, Lix LM, Yogendran M, Morin SN, Metge CJ, Leslie WD. Population-based trends in osteoporosis management after new initiations of long-term systemic glucocorticoids (1998-2008). J Clin Endocrinol Metab. 2012 ; 97 (4) : 1236-1242.
PubMed
3) 厚生統計協会編 : 厚生の指標臨時増刊 国民衛生の動向 2003年第50巻第9号. 厚生統計協会, 2003.
 
4) Ensrud KE, Thompson DE, Cauley JA, et al. : Prevalent vertebral deformities predict mortality and hospitalization in older women with low bone mass. Fracture Intervention Trial Research Group. J Am Geriatr Soc. 2000 ; 48 (3) : 241-249.
 
5) Lu-Yao GL, Baron JA, Barrett JA, et al. : Treatment and survival among elderly Americans with hip fractures : a population-based study. Am J Public Health. 1994 ; 84 (8) : 1287-1291.
PubMed
6) Roux C, Seeman E, Eastell R,et al. : Efficacy of risedronate on clinical vertebral fractures within six months. Curr Med Res Opin. 2004 ; 20 (4) : 433-439.
PubMed
7) Grossman JM, Gordon R, Ranganath VK, et al. : American College of Rheumatology 2010 recommendations for the prevention and treatment of glucocorticoidinduced osteoporosis. Arthritis Care Res (Hoboken). 2010 ; 62 (11) : 1515-1526.
PubMed
8) Suda M, et al. : Effects of quality indicator monitoring for glucocorticoid-induced osteoporosis and trends of drug treatment in a Japanese hospital. Int J Rheum Dis. 2018 ; 21 (5) : 975-981.
 
9) Confavreux CB, Canoui-Poitrine F, Schott AM, Ambrosi V, Tainturier V, Chapurlat RD : Persistence at 1 year of oral antiosteoporotic drugs : a prospective study in a comprehensive health insurance database. Eur J Endocrinol. 2012 ; 166 (4) : 735-741.
 
10) Dore RK, Cohen SB, Lane NE, Palmer W, Shergy W, Zhou L, et al. : Effects of denosumab on bone mineral density and bone turnover in patients with rheumatoid arthritis receiving concurrent glucocorticoids or bisphosphonates. Ann Rheum Dis. 2010 ; 69 (5) : 872-875.
PubMed
11) Saag KG, Zanchetta JR, Devogelaer JP, Adler RA, Eastell R, See K, et al. : Effects of teriparatide versus alendronate for treating glucocorticoid-induced osteoporosis : thirty-six-month results of a randomized, double-blind, controlled trial. Arthritis Rheum. 2009 ; 60 (11) : 3346-3355.
PubMed
P.112 掲載の参考文献
1) 恩田光子, 小林暁峯, 黒田和夫, 他 : 薬剤管理指導が患者アウトカムに与える効果に関する研究. 医療マネジメント学会雑誌. 医療マネジメント学会, 2004 ; 5 : 349-353.
Medical*Online
2) 恩田光子, 小林暁峯, 黒田和夫, 他 : 薬剤管理指導業務が臨床アウトカムに与える影響に関する研究. 病院管理. 2004 ; 41 (4) : 255-262.
 
3) Chisholm-Burns MA, Kim Lee J, Spivey CA, et al. : US pharmacists' effect as team members on patient care : systematic review and meta-analyses. Med Care. 2010 ; 48 (10) : 923-933.
PubMed
4) 木幡華子, 計良貴之, 田中恒明, 他 : 薬剤師の病棟配置が薬物療法の質および医療安全に与える影響. 日本病院薬剤師会誌. 2012 ; 48 (2) : 173-176.
 
5) 日本病院薬剤師会総務部 : 平成28年度 病院薬剤部門の現状調査 集計結果報告. 日本病院薬剤師会誌. 2017 ; 53 (7) : 751-819.
 

第8章 手術・処置

P.117 掲載の参考文献
1) 一般社団法人 日本医療安全調査機構 : 医療事故の再発防止に向けた提言 第1号 中心静脈穿刺合併症に係る死亡の分析-第1報-. 2017.
 
2) McGee DC, Gould MK : Preventing complications of central venous catheterization. N Engl J Med. 2003 ; 348 (12) : 1123-1133.
PubMed
3) Graham AS, Ozment C, et al. : Videos in clinical medicine. Central venous catheterization. N Engl J Med. 2007 ; 356 (21) : e21.
PubMed
4) Hind D, Calvert N, McWilliams R, et al. : Ultrasonic locating devices for central venous cannulation : meta-analysis. BMJ. 2003 ; 327 (7411) : 361.
PubMed
P.120 掲載の参考文献
1) Kirkland KB, Briggs JP, Trivette SL, Wilkinson WE, Sexton DJ : The impact of surgical-site infections in the 1990s : attributable mortality, excess length of hospitalization, and extra costs. Infect Control Hosp Epidemiol. 1999 ; 20 (11) : 725-730.
PubMed
2) CDC : Guideline for the Prevention of Surgical Site Infection, 1999. Infect Cont Hosp Epidemiol. 1999 ; 20 : 247-278.
 
3) Bratzler DW, Houck PM : Antimicrobial prophylaxis for surgery : an advisory statement from the National Surgical Infection Prevention Project. Clin Infect Dis. 2004 ; 38 (12) : 1706-1715.
PubMed
4) Edwards FH, Engelman RM, Houck P, Shahian DM, Bridges CR : The Society of Thoracic Surgeons Practice Guideline Series : Antibiotic Prophylaxis in Cardiac Surgery, Part I : Duration. Ann Thorac Surg. 2006 ; 81 (1) : 397-404.
 
5) The Joint Commission ; Specifications Manual for National Hospital Inpatient Quality Measures, Version 4.3a SCIP-Inf-3 Prophylactic Antibiotic Discontinued Within 24 Hours After Surgery End Time (48 hours for CABG or Other Cardiac Surgery) http://www.jointcommission.org/assets/1/6/NHQM_v4_3a_PDF_10_2_2013.zip (2015. 06. 04 available)
 
6) America's Hospitals : Improving Quality and Safety ; The Joint Commission's Annual Report 2015.
 
P.123 掲載の参考文献
1) America's Hospitals : Improving Quality and Safety ; The Joint Commission's Annual Report 2015.
 
2) The Joint Commission ; Specifications Manual for National Hospital Inpatient Quality Measures, Version 4.3a SCIP-Inf-2 Prophylactic Antibiotic Received Within One Hour Prior to Surgical Incision. http://www.jointcommission.org/assets/1/6/NHQM_v4_3a_PDF_10_2_2013.zip (2015. 06. 04 available)
 
P.124 掲載の参考文献
1) America's Hospitals : Improving Quality and Safety ; The Joint Commission's Annual Report 2014. http://www.jointcommission.org/assets/1/18/TJC_Annual_Report_2014_FINAL.pdf (2015. 06. 04 available)
 
2) The Joint Commission ; Specifications Manual for National Hospital Inpatient Quality Measures, Version 4.3a SCIP-Inf-4 Cardiac Surgery Patients With Controlled Postoperative Blood Glucose. http://www.jointcommission.org/assets/1/6/NHQM_v4_3a_PDF_10_2_2013.zip (2015. 06. 04 available)
 
3) Zerr KJ, Furnary AP, Grunkemeier GL, Bookin S, Kanhere V, Starr A : Glucose control lowers the risk of wound infection in diabetics after open heart operations. Ann Thorac Surg. 1997 ; 63 (2) : 356-361.
PubMed
4) Latham R, Lancaster AD, Covington JF, Pirolo JS, Thomas CS Jr : The association of diabetes and glucose control with surgical-site infections among cardiothoracic surgery patients. Infect Control Hosp Epidemiol. 2001 ; 22 (10) : 607-612.
PubMed
5) van den Berghe G, Wouters P, Weekers F, Verwaest C, Bruyninckx F, Schetz M, Vlasselaers D, Ferdinande P, Lauwers P, Bouillon R : Intensive insulin therapy in critically ill patients. N Engl J Med. 2001 ; 345 (19) : 1359-1367.
 
6) Lazar HL, McDonnell M, Chipkin SR, Furnary AP, Engelman RM, Sadhu AR, Bridges CR, Haan CK, Svedjeholm R, Taegtmeyer H, Shemin RJ ; Society of Thoracic Surgeons Blood Glucose Guideline Task Force. The Society of Thoracic Surgeons practice guideline series : Blood glucose management during adult cardiac surgery. Ann Thorac Surg. 2009 ; 87 (2) : 663-669.
 
P.128 掲載の参考文献
1) Kirkland KB, Briggs JP, Trivette SL, Wilkinson WE, Sexton DJ : The impact of surgical-site infections in the 1990s : attributable mortality, excess length of hospitalization, and extra costs. Infect Control Hosp Epidemiol 1999 ; 20 : 725-730.
PubMed
2) CDC : Guideline for the Prevention of Surgical Site Infection, 1999. Infect Cont Hosp Epidemiol 1999 ; 20 : 247-278.
 
3) The Joint Commission ; Specifications Manual for National Hospital Inpatient Quality Measures, Version 4.3a SCIP-Inf-1 Prophylactic Antibiotic Received Within One Hour Prior to Surgical Incision. http://www.jointcommission.org/assets/1/6/NHQM_v4_3a_PDF_10_2_2013.zip (2015. 06. 04 available)
 
4) America's Hospitals : Improving Quality and Safety ; The Joint Commission's Annual Report 2015.
 
P.129 掲載の参考文献
1) Sakuma M, Nakamura M, Yamada N, et al. : Venous thromboembolism-Deep vein thrombosis with pulmonary embolism, deep vein thrombosis alone, pulmonary embolism alone. Circ J. 2009 ; 73 : 305-309.
PubMed
2) Nakamura M, Fujioka H, Yamada N, et al. : Clinical characteristics of acute pulmonary thromboembolism in Japan : results of a multicenter registry in the Japanese Society of Pulmonary Embolism Research. Clin Cardiol. 2001 ; 24 : 132-138.
PubMed
3) 肺血栓塞栓症/深部静脈血栓症 (静脈血栓塞栓症) 予防ガイドライン作成委員会 : 肺血栓塞栓症/深部静脈血栓症 (静脈血栓塞栓症) 予防ガイドライン. Medical Front International Limited, 東京, 2004.
 
4) 古家仁, 瀬尾憲正, 北口勝康, 他 : 社団法人日本麻酔科学会周術期肺塞栓症調査 2005年結果 (短報). Therapeutic research. 2008 ; 29 : 659-661.
Medical*Online
5) America's Hospitals : Improving Quality and Safety ; The Joint Commission's Annual Report 2015.
 
6) The Joint Commission ; Specifications Manual for National Hospital Inpatient Quality Measures, Version 4.3a SCIP-VTE-2. http://www.jointcommission.org/assets/1/6/NHQM_v4_3a_PDF_10_2_2013.zip (2015. 06. 04 available)
 
P.131 掲載の参考文献
1) Sakuma M, Nakamura M, Yamada N, et al. : Venous thromboembolism-Deep vein thrombosis with pulmonary embolism, deep vein thrombosis alone, pulmonary embolism alone. Circ J. 2009 ; 73 : 305-309.
PubMed
2) Nakamura M, Fujioka H, Yamada N, et al. : Clinical characteristics of acute pulmonary thromboembolism in Japan : results of a multicenter registry in the Japanese Society of Pulmonary Embolism Research. Clin Cardiol. 2001 ; 24 : 132-138.
PubMed
3) 肺血栓塞栓症/深部静脈血栓症 (静脈血栓塞栓症) 予防ガイドライン作成委員会 : 肺血栓塞栓症/深部静脈血栓症 (静脈血栓塞栓症) 予防ガイドライン. Medical Front International Limited, 東京, 2004.
 
4) America's Hospitals : Improving Quality and Safety ; The Joint Commission's Annual Report 2015.
 
5) The Joint Commission ; Specifications Manual for National Hospital Inpatient Quality Measures, Version 4.3b VTE-6 Incidence of Potentially-Preventable Venous Thromboembolism. http://www.jointcommission.org/assets/1/6/HIQR_Jan2014_v4_3b.zip (2015. 06. 04 available)
 
P.132 掲載の参考文献
1) The Australian Council on Healthcare Standards (ACHS). ANAESTHESIA AND PERIOPERATIVE CARE VERSION 6, Retrospective data in full ACIR 2008-2015. http://www.achs.org.au/media/111961/anaesthesia_and_perioperative_care_long_report_2008-2015.pdf (2017. 05. 31 available)
 
P.133 掲載の参考文献
1) Moslem-Kebria M, El-Nashar SA, Aletti GD et al. : Intraoperative Hypothermia during Cytoreductive Surgery for Ovarian Cancer and Perioperative Morbidity. Obstet Gynecol. 2012 ; 119 : 590-596.
 
2) The Joint Commission ; Specifications Manual for National Hospital Inpatient Quality Measures, Version 4.3a SCIP-Inf-10 Surgery Patients with Perioperative Temperature Management. http://www.jointcommission.org/assets/1/6/NHQM_v4_3a_PDF_10_2_2013.zip (2015.06.04 available)
 
3) Kurz A, Sessler DI, Lenhardt R : Perioperative Normothermia to Reduce the Incidence of Surgicalwound Infection and Shorten Hospitalization. Study of Wound Infection and Temperature Group. N Engl J Med. 1996 ; 334 : 1209-1215.
 
4) Frank SM, Fleisher LA, Breslow MJ et al. : Perioperative Maintenance of Normothermia Reduces the Incidence of Morbid Cardiac Events. A Randomized Clinical Trial. JAMA. 1997 ; 277 : 1127-1134.
PubMed
5) Schmied H, Kurz A, Sessler DI et al. : Mild Hypothermia Increases Blood Loss and Transfusion Requirements during Total Hip. Lancet. 1996 ; 347 : 289-292.
PubMed

第9章 生活習慣

P.138 掲載の参考文献
1) 日本糖尿病学会編著 : 糖尿病診療ガイドライン 2016. 南江堂, 2016.
 
2) 日本糖尿病学会. 日本老年医学会の合同委員会 高齢者糖尿病の血糖コントロール目標 2016.
 
P.141 掲載の参考文献
1) Thom T, Haase N, Rosamond W, Howard VJ, Rumsfeld J, Manolio T, Zheng ZJ, Flegal K, O'Donnell C, Kittner S, Lloyd-Jones D, Goff DC Jr, Hong Y, Adams R, Friday G, Furie K, Gorelick P, Kissela B, Marler J, Meigs J, Roger V, Sidney S, Sorlie P, Steinberger J, Wasserthiel-Smoller S, Wilson M, Wolf P : Heart disease and stroke statistics-2006 update : a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation. 2006 ; 113 (6) : e85-151.
PubMed
2) Psaty BM, Manolio TA, Smith NL, Heckbert SR, Gottdiener JS, Burke GL, et al. : Time trends in high blood pressure control and the use of antihypertensive medications in older adults : the Cardiovascular Health Study. Arch Intern Med. 2002 ; 162 (20) : 2325-2332.
PubMed
3) Turnbull F : Effects of different blood-pressure-lowering regimens on major cardiovascular events : results of prospectively-designed overviews of randomised trials. Lancet. 2003 ; 362 (9395) : 1527-1535.
PubMed
4) Blood Pressure Lowering Treatment Trialists' Collaboration, Turnbull F, Neal B, Pfeffer M, Kostis J, Algert C, Woodward M, et al. : Blood pressuredependent and independent effects of agents that inhibit the reninangiotensin system. J Hypertens. 2007 ; 25 (5) : 951-958.
PubMed
5) James PA, Oparil S, Carter BL, Cushman WC, Dennison-Himmelfarb C, Handler J, Lackland DT, LeFevre ML, MacKenzie TD, Ogedegbe O, Smith SC Jr, Svetkey LP, Taler SJ, Townsend RR, Wright JT Jr, Narva AS, Ortiz E : 2014 evidence-based guideline for the management of high blood pressure in adults : report from the panel members appointed to the Eighth Joint National Committee (JNC 8). JAMA. 2014 ; 311 (5) : 507-520.
 
6) 日本高血圧学会高血圧治療ガイドライン作成委員会編 : 高血圧治療ガイドライン 2014. 日本高血圧学会, 2014.
 
7) Julius S, Kjeldsen SE, Weber M, Brunner HR, Ekman S, Hansson L, et al. : Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine : the VALUE randomised trial. Lancet. 2004 ; 363 (9426) : 2022-2031.
 
8) NHS Employers Quality and Outcomes Framework guidance for GMS contract 2011/12 Delivering investment in general practice April 2011. http://www.nhsemployers.org/Aboutus/Publications/Documents/QOF_guidance_GMS_contract_2011_12.pdf (2014. 06. 24 available)
 
9) SPRINT Research Group, Wright JT Jr, Williamson JD, Whelton PK, et al. : A Randomized Trial of Intensive versus Standard Blood-Pressure Control. N Engl J Med. 2015 ; 373 (22) : 2103-2116.
 
10) Lewington S, Clarke R, Qizilbash N, et al. : Age-specific relevance of usual blood pressure to vascular mortality : a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet. 2002 ; 360 (9349) : 1903-1913.
PubMed
11) Delgado J, Bowman K, Ble A, et al. : Blood Pressure Trajectories in the 20 Years Before Death. JAMA Intern Med. 2018 ; 178 (1) : 93-99.
PubMed
P.145 掲載の参考文献
1) 日本動脈硬化学会 (編) : 動脈硬化性疾患予防ガイドライン 2017年版. 日本動脈硬化学会, 2017.
 
P.146 掲載の参考文献
1) Criteria, P. S. : HYPERTENSION (HTN) Algorithm for Measures Calculation-EHRS (Analytic Narrative and Data Elements) PATIENT SELECTION CRITERIA Include if ALL the following criteria are met : At least two face-toface office visits with the physician, physicians' assistant, or nurse practitioner during the measurement time period Is aged 18 years and older at the beginning of the measurement time period Patient has a documented diagnosis of Hypertension HYPERTENSION (HTN) Algorithm for Measures Calculation-EHRS (Analytic Narrative and Data Elements) At least two face-to-face office visits with physician, physicians' assistant, or nurse. Blood Pressure 2006 : 1-12.
 
2) Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL, et al. : Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 2003 ; 42 (6) : 1206-1252.
PubMed
3) American Medical Association. HYPERTENSION (HTN) Algorithm for Measures calculation-EHRS (Analytic Narrative and Data Elements). http://www.ama-assn.org/ama1/pub/upload/mm/pcpi/htnanalyticnarr307_7.pdf (2014. 06. 24 avaliable)
 
4) NICE Menu of Indicators. The percentage of patients under 80 years old with hypertension in whom the last recorded blood pressure (measured in the preceding 9 months) is 140/90 or less. http://www.nice.org.uk/aboutnice/qof/indicators.jsp (2014. 06. 24 available)
 

第10章 脳・神経

P.151 掲載の参考文献
1) Berkhemer OA et al. : A randomized trial of intraarterial treatment for acute ischemic stroke. N Engl J Med. 2015 ; 372 (1) : 11-20.
PubMed
P.153 掲載の参考文献
1) America's Hospitals : Improving Quality and Safety ; The Joint Commission's Annual Report 2015.
 
2) The Joint Commission ; Specifications Manual for National Hospital Inpatient Quality Measures, Version 4.3a STK-2 Discharged on Antithrombotic Therapy. http://www.jointcommission.org/assets/1/6/NHQM_v4_3a_PDF_10_2_2013.zip (2015. 06. 04 available)
 
3) 日本脳卒中学会 脳卒中ガイドライン委員会編 : 脳卒中治療ガイドライン 2015. 協和企画, 2017.
 
P.155 掲載の参考文献
1) America's Hospitals : Improving Quality and Safety ; The Joint Commission's Annual Report 2015.
 
2) The Joint Commission ; Specifications Manual for National Hospital Inpatient Quality Measures, Version 4.3a STK-3 Anticoagulation therapy for atrial fibrillation/flutter. http://www.jointcommission.org/assets/1/6/NHQM_v4_3a_PDF_10_2_2013.zip (2015. 06. 04 available)
 
3) 日本脳卒中学会 脳卒中ガイドライン委員会編 : 脳卒中治療ガイドライン 2015. 協和企画, 2017.
 
P.157 掲載の参考文献
1) America's Hospitals : Improving Quality and Safety ; The Joint Commission's Annual Report 2015.
 
2) The Joint Commission ; Specifications Manual for National Hospital Inpatient Quality Measures, Version 4.3a STK-10 Assessed for Rehabilitation. http://www.jointcommission.org/assets/1/6/NHQM_v4_3a_PDF_10_2_2013.zip (2015. 06. 04 available)
 
3) 日本脳卒中学会 脳卒中ガイドライン委員会編 : 脳卒中治療ガイドライン 2015. 協和企画, 2017.
 

第11章 心血管

P.160 掲載の参考文献
1) Goto Y. Cardiac rehabilitation : evidence and perspective. J Cardiol Jpn Ed. 2009 : 195-215.
 
2) 日本循環器学会, 他 (編) : 心血管疾患におけるリハビリテーションに関するガイドライン (2012年改訂版).
 
3) 柳英利, 進藤直久, 大嶋直志, 他 : 当院における急性心筋梗塞退院後の外来心臓リハビリテーションの継続率向上に向けた取り組み. 日本心臓リハビリテーション学会. 心臓リハビリテーション. 2013 ; 18 (2) : 183-192.
 
P.162 掲載の参考文献
1) America's Hospitals : Improving Quality and Safety ; The Joint Commission's Annual Report 2015.
 
2) The Joint Commission ; Specifications Manual for National Hospital Inpatient Quality Measures, Version 4.3b AMI-8a Primary PCI Received Within 90 Minutes of Hospital Arrival. http://www.jointcommission.org/assets/1/6/HIQR_Jan2014_v4_3b.zip (2015. 06. 04 available)
 
3) Antman EM, et al. : ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction. Circulation. 2004 ; 110 : 82-292.
 
4) Flynn A, et al. : Trends in door-toballoon time and mortality in patients with STEMI undergoing PPCI. Arch Intern Med. 2010 ; 170 : 1842-1849.
 
P.165 掲載の参考文献
1) America's Hospitals : Improving Quality and Safety ; The Joint Commission's Annual Report 2015.
 
2) The Joint Commission ; Specifications Manual for National Hospital Inpatient Quality Measures, Version 4.3b AMI-3 ACEI or ARB for LVSD. http://www.jointcommission.org/assets/1/6/HIQR_Jan2014_v4_3b.zip (2015. 06. 04 available)
 
3) ACC/AHA Clinical Performance Measures for Adults With ST-Elevation and Non ST-Elevation Myocardial Infarction : A Report of the American College of Cardiology/American Heart Association Task Force on Performance Measures (Writing Committee to Develop Performance Measures on ST-Elevation and Non-ST-Elevation Myocardial Infarction). Circulation. 2006 ; 113 : 732-761.
 
P.168 掲載の参考文献
1) America's Hospitals : Improving Quality and Safety ; The Joint Commission's Annual Report 2015.
 
2) The Joint Commission ; Specifications Manual for National Hospital Inpatient Quality Measures, Version 4.3b AMI-1 Aspirin at Arrival. http://www.jointcommission.org/assets/1/6/HIQR_Jan2014_v4_3b.zip (2015. 06. 04 available)
 
P.170 掲載の参考文献
1) American College of Cardiology Foundation (ACCF) /American Heart Association (AHA) /Physician Consortium for Performance Improvement(R) (PCPI(TM)), Heart Failure Performance Measurement Set, ACCF/AHA Approved December 2010, PCPI Approved January 2011, Updated May 15, 2012. http://www.ama-assn.org/ama1/pub/upload/mm/pcpi/hfset-12-5.pdf (2014. 07. 07 available)
 
2) The Joint Commission ; Specifications Manual for National Hospital Inpatient Quality Measures, Version 4.3b HF-3 ACEI or ARB for LVSD. http://www.jointcommission.org/assets/1/6/HIQR_Jan2014_v4_3b.zip (2015. 06. 04 available)
 
3) America's Hospitals : Improving Quality and Safety ; The Joint Commission's Annual Report 2015.
 
4) Yancy CW, et al. : 2013 ACCF/AHA guideline for the management of heart failure : a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. Circulation.2013 ; 128 (16) : e240.
 
P.173 掲載の参考文献
1) The Joint Commission ; Specifications Manual for National Hospital Inpatient Quality Measures, Version 4.3b HF-2 Evaluation of LVS Function. http://www.jointcommission.org/assets/1/6/HIQR_Jan2014_v4_3b.zip (2015. 06. 04 available)
 
2) Bonow RO, Ganiats TG, Beam CT, Blake K, Casey DE Jr, Goodlin SJ, Grady KL, Hundley RF, Jessup M, Lynn TE, Masoudi FA, Nilasena D, Pina IL, Rockswold PD, Sadwin LB, Sikkema JD, Sincak CA, Spertus J, Torcson PJ, Torres E, Williams MV, Wong JB : ACCF/AHA/AMA-PCPI 2011 performance measures for adults with heart failure : a report of the American College of Cardiology Foundation/American Heart Association Task Force on Performance Measures and the American Medical Association-Physician Consortium for Performance Improvement.Circulation. 2012 ; 125 (19) : 2382-2401.
 
3) Yancy CW, et al. : 2013 ACCF/AHA guideline for the management of heart failure : a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. Circulation. 2013 ; 128 (16) : e240.
 
4) 日本循環器学会 : 急性・慢性心不全診療ガイドライン (2017年改訂版) Guidelines for Diagnosis and Treatment of Acute and Chronic Heart Failure (JCS 2017/JHFS 2017).
 
P.176 掲載の参考文献
1) American College of Cardiology Foundation (ACCF) /American Heart Association (AHA) /Physician Consortium for Performance Improvement(R) (PCPI(TM)), Heart Failure Performance Measurement Set, ACCF/AHA Approved December 2010, PCPI Approved January 2011, Updated May 15, 2012. http://www.ama-assn.org/ama1/pub/upload/mm/pcpi/hfset-12-5.pdf (2014. 07. 07 available)
 
2) Yancy CW, et al. : 2013 ACCF/AHA guideline for the management of heart failure : a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. Circulation.2013 ; 128 (16) : e240.
 
3) Bonow RO, Ganiats TG, Beam CT, Blake K, Casey DE Jr, Goodlin SJ, Grady KL, Hundley RF, Jessup M, Lynn TE, Masoudi FA, Nilasena D, Pina IL, Rockswold PD, Sadwin LB, Sikkema JD, Sincak CA, Spertus J, Torcson PJ, Torres E, Williams MV, Wong JB : ACCF/AHA/AMA-PCPI 2011 performance measures for adults with heart failure : a report of the American College of Cardiology Foundation/American Heart Association Task Force on Performance Measures and the American Medical Association-Physician Consortium for Performance Improvement.Circulation. 2012 ; 125 (19) : 2382-2401.
 
P.177 掲載の参考文献
1) Agency for Healthcare Research and Quality ; INPATIENT QUALITY INDICATOR v6.0 BENCHMARK DATA TABLES. https://www.qualityindicators.ahrq.gov/Downloads/Modules/IQI/V60/Version_60_Benchmark_Tables_IQI.pdf (2018. 08. 06 available)
 
2) Agency for Healthcare Research and Quality. AHRQ Quality indicators Inpatient quality indicators technical specifications IQI #30 PCI Mortality rate. https://www.qualityindicators.ahrq.gov/Downloads/Modules/IQI/V60/TechSpecs/IQI_30_Percutaneous_Coronary_Intervention_(PCI)_Mortality_Rate.pdf (2017. 05. 31 available)
 
P.180 掲載の参考文献
1) America's Hospitals : Improving Quality and Safety ; The Joint Commission's Annual Report 2015.
 
2) 循環器病の診断と治療に関するガイドライン (2006). Guidelines for Secondary Prevention of Myocardial Infarction (JCS 2006). Prevention, (Jcs), 1-52.
 
3) 循環器病の診断と治療に関するガイドライン (2008). Guidelines for the management of patients with ST-elevation myocardial infarction (JCS 2008). Circulation Journal. 72 : 1347-1442.
 
4) Foresi A, Cavigioli G, Signorelli G, Pozzoni MB, Olivieri D : Is the use of beta-blockers in COPD still an unresolved dilemma? Respiration ; international review of thoracic diseases 2010 ; 80 (3) : 177-187.
PubMed
5) The Joint Commission ; Specifications Manual for National Hospital Inpatient Quality Measures, Version 4.3b AMI-2 Aspirin Prescribed at Discharge. http://www.jointcommission.org/assets/1/6/HIQR_Jan2014_v4_3b.zip (2015. 06. 04 available)
 
6) The Joint Commission ; Specifications Manual for National Hospital Inpatient Quality Measures, Version 4.3b AMI-5 Beta-Blocker Prescribed at Discharge. http://www.jointcommission.org/assets/1/6/HIQR_Jan2014_v4_3b.zip (2015. 06. 04 available)
 
7) The Joint Commission ; Specifications Manual for National Hospital Inpatient Quality Measures, Version 4.3b AMI-10 Statin Prescribed at Discharge. http://www.jointcommission.org/assets/1/6/HIQR_Jan2014_v4_3b.zip (2015. 06. 04 available)
 
8) Hector MM, Christopher PC, Xin Z, et al. : Quality of acute myocardial infarction care and outcomes in 33, 997 patients aged 80 years or older : Findings from Get With The Guidelines-Coronary Artery Disease (GWTG-CAD).
 
P.181 掲載の参考文献
1) The Joint Commission ; Specifications Manual for National Hospital Inpatient Quality Measures, Version 4.3b HF-1 Discharge Instructions http://www.jointcommission.org/assets/1/6/HIQR_Jan2014_v4_3b.zip (2015. 06. 04 available)
 
2) Yancy CW, et al. : 2013 ACCF/AHA guideline for the management of heart failure : a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. Circulation. 2013 ; 128 (16) : e240.
 
3) VanSuch M, Naessens JM, Stroebel RJ, Huddleston JM, Williams AR. : Effect of discharge instructions on readmission of hospitalised patients with heart failure : do all of the Joint Commission on Accreditation of Healthcare Organizations heart failure core measures reflect better care?. Qual Saf Health Care. 2006 ; 15 (6), 414-417.
PubMed

第12章 慢性腎臓病

P.184 掲載の参考文献
1) Nissennson AR, Collins AJ, Hurley J et al. : Opportunities for Improving the Care of Patients with Chronic Renal Insufficiency : Current Practice Patterns. J Am Soc Nephrol 2001 ; 12 : 1713-1720.
 
2) Philipneri MD : Delivery patterns of recommended chronic kidney disease care in clinical practice : administrative claims-based analysis and systematic literature review. CLin Exp Nephrol 2008 ; 12 : 41-52.
PubMed
3) Karunaratne K, Stevens P, Irving J et al. : The impact of pay for performance on the control of blood pressure in people with chronic kidney disease stage 3-5. Neprhol Dial Transplant 2013 ; 28 : 2107-2116.
PubMed
P.185 掲載の参考文献
1) 日本透析医学会 : 2015年版慢性腎臓病患者における腎性貧血治療のガイドライン.
 
2) KDOQI Clinical practice Guidelines and Clinical Practice Recommendations for Anemia in Chronic Kidney Disease. Am J Kidney Dis 2006 ; 47 (5 Suppl 3) : S11-145.
 
3) Centers for Medicare and Medicaid services ; Quality Measurement and Health Assessment Group (QMHAG) : ESRD-Anemia Management CPM Ia : Hemoglobin Control for ESA Therapy. http://www.dialysisreports.org/pdf/esrd/public-measures/Hemoglobin_Control_for_ESA_Therapy.pdf (2014. 05. 13 available)
 
4) United States Renal Data System. Clinical Indicators and Preventive Care. http://www.usrds.org/2014/view/Default.aspx (2015. 08. 07 available)
 
P.187 掲載の参考文献
1) NKF KDOQI Clinical Practice Guidelines and Clinical Practice Recommendations 2006 Updates Hemodialysis Adequacy and Peritoneal Dialysis Adequacy. Am J Kidney Dis. 2006 ; Supple 1.
 
2) The Official U.S. Government Site for Medicare. Dialysis Facility Compare. https://www.medicare.gov/dialysisfacilitycompare/#data/about-data (2017. 10. 24 available)
 
3) The University of Michigan Kidney Epidemiology and Cost Center : Guide to the Quarterly Dialysis Facility Compare-Preview for October 2017 Report : Overview, Methodology, and Interpretation. July 2017. https://www.dialysisdata.org/sites/default/files/content/Methodology/DFCReportGuide.pdf (2017. 10. 24 available)
 
4) 日本透析医学会 : 維持血液透析ガイドライン 血液透析処方. 透析会誌. 2013 ; 46 : 587-632.
 
5) 日本透析医学会 : 2009年版日本透析医学会 腹膜透析ガイドライン. 透析会誌. 2009 ; 42 : 285-315.
 
6) United States Renal Data System : Clinical Indicators and Preventive Care. https://www.usrds.org/2016/view/v2_03.aspx (2017. 08. 07 available)
 

第13章 眼・耳鼻咽喉

P.191 掲載の参考文献
1) Richard M, et al. : Systemic review of topical antimicrobial therapy for acute otitis externa. Otolaryngol Head Neck Surg 2006 ; 134 (1 Suppl) : S24-48.
 
2) Rosenfeld RM, et al. : Clinical practice guideline : acute otitis externa. Otolaryngol Head Neck Surg 2014 ; 150 (1 Suppl) : S1-24.
 
3) AOE/OME Work Group American Academy of Otolaryngology-Head and Neck Surgery (AAO-HNS) Foundation/Physician Consortium for Performance Improvement(R) (PCPI) ; Acute Otitis Externa (AOE) /Otitis Media with Effusion (OME) Physician Performance Measurement Set. http://www.ama-assn.org/ama1/pub/upload/mm/pcpi/acute-otitis-externaotitis-media-worksheets.pdf (2014. 04. 09 available)
 
P.192 掲載の参考文献
1) The Australian Council on Healthcare Standards (ACHS). OPHTHALMOLOGY VERSION 5 Retrospective data in full ACIR 2008-2015. http://www.achs.org.au/media/112017/ophthalmology_long_report_2008-2015.pdf (2017. 05. 31 available)
 

第14章 救急

P.198 掲載の参考文献
1) 25米国小児専門病院 (Pediatric Emergency Care Applied Network, Lancet 374 ; 1160, 2009).
 
2) 日本の一般病院 (藤沢市民病院 : 2011年小児救急学会発表, *NICEガイドラインを導入).
 
3) Brenner DJ, Hall EJ : Computed Tomography-An Increasing Source of Radiation Exposure. N Engl J Med. 2007 ; 357 : 2277-2284.
PubMed
4) Stiell IR, et al. : The Canadian CT Head Rule for patients with minor head injury. Lancet. 2001 ; 357 : 1391-1396.
 
5) Smits M, et al. : External Validation of the Canadian CT Head Rule and the New Orleans Criteria for CT Scanning in Patients With Minor Head Injury. JAMA. 2005 ; 294 : 1519-1525.
PubMed
6) Kuppermann N, et al. : Identification of children at very low risk of clinically-important brain injuries after head trauma : a prospective cohort study. Lancet. 2009 ; 374 : 1160-1170.
PubMed
7) Patricia C, et al. : Should a Head-Injured Child Receive a Head CT Scan? A Systematic Review of Clinical Prediction Rules. Pediatrics. 2009 ; 124 : e145-154.
 
8) Oman JA, et al. : Performance of a Decision Rule to Predict Need for Computed Tomography Among Children With Blunt Head Trauma. Pediatrics. 2006 ; 117 : e238-246.
PubMed
9) Bulas D, et al. : Image Gently : improving health literacy for parents about CT scans for children. Pediatr Radiol. 2009 ; 39 : 112-116.
PubMed
10) Ishida Y, Manabe A, Oizumi A, Otani N, Hirata M, Urayama K, Saida Y, Kusakawa I, Fukui T : Association between Parental Preference and Head Computed Tomography in Children with Minor Blunt Head Trauma. JAMA Pediatr. 2013 ; 167 : 491-492.
PubMed

第15章 腫瘍

P.207 掲載の参考文献
1) Ash D, Barrett A, Hinks A, Squire C : Re-audit of radiotherapy waiting times 2003. Clin Oncol (R Coll Radiol). 2004 ; 16 (6) : 387-394.
PubMed
2) Albert JM, Das P : Quality indicators in radiation oncology. Int J Radiat Oncol Biol Phys. 2013 ; 85 (4) : 904-911.
PubMed
3) Chen Z, King W, Pearcey R, et al. : The relationship between waiting time for radiotherapy and clinical outcomes : a systematic review of the literature. Radiother Oncol. 2008 ; 87 (1) : 3-16.
PubMed
4) van Harten MC, Hoebers FJ, Kross KW, et al. : Determinants of treatment waiting times for head and neck cancer in the Netherlands and their relation to survival. Oral Oncol. 2015 ; 51 (3) : 272-278.
PubMed
5) Corradini S, Niemoeller OM, Niyazi M, et al. : Timing of radiotherapy following breast-conserving surgery : outcome of 1393 patients at a single institution. Strahlenther Onkol. 2014 ; 190 (4) : 352-357.
 
P.209 掲載の参考文献
1) American Medical Association AMA-PCPI Approved Quality measures. http://www.ama-assn.org/apps/listserv/x-check/qmeasure.cgi?submit=PCPI (2015. 06. 29 available)
 
2) 大腸癌研究会編 : 大腸癌治療ガイドライン医師用 2016年版. 金原出版, 2016.
 
3) Van Cutsem EJ, Oliveira J ; ESMO Guidelines Working Group. : Colon cancer : ESMO clinical recommendations for diagnosis, adjuvant treatment and follow-up. Ann Oncol. 2008 ; 19 Suppl 2 : ii29-30.
 
4) Andre T, Quinaux E, Louvet C, et al. : Phase III study comparing a semimonthly with a monthly regimen of fluorouracil and leucovorin as adjuvant treatment for stage II and III colon cancer patients : final results of GERCOR C96.1. J Clin Oncol. 2007 ; 25 (24) : 3732-3738.
PubMed
5) NIH consensus conference. Adjuvant therapy for patients with colon and rectal cancer. JAMA. 1990 ; 264 (11) : 1444-1450.
PubMed
6) Lembersky BC, et al. : Oral uracil and tegafur plus leucovorin compared with intravenous fluorouracil and leucovorin in stage II and III carcinoma of the colon : results from National Surgical Adjuvant Breast and Bowel Project Protocol C-06. J Clin Oncol. 2006 ; 24 (13) : 2059-2064.
PubMed
7) Andre T, et al. : Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer. N Engl J Med. 2004 ; 350 (23) : 2343-2351.
PubMed
8) NIH consensus conference : Adjuvant therapy for patients with colon and rectal cancer. JAMA. 1990 ; 264 (11) : 1444-1450.
PubMed
9) Wolmark N, Rockette H, Fisher B, et al. : The benefit of leucovorinmodulated fluorouracil as postoperative adjuvant therapy for primary colon cancer : results from National Surgical Adjuvant Breast and Bowel Project protocol C-03. J Clin Oncol. 1993 ; 11 (10) : 1879-1887.
PubMed
P.211 掲載の参考文献
1) 診療の質指標 Quality Indicatorがん対策における管理評価指標群の策定とその計測システムの確立に関する研究班. http://qi.ncc.go.jp/index.html (2014. 02. 24 available)
 
2) 胃癌治療ガイドライン 医師用 2014年5月改訂. 日本胃癌学会編.
 
3) Sakuramoto S, et al. : Adjuvant chemotherapy for gastric cancer with S-1, an oral fluoropyrimidine. N Engl J Med. 2007 ; 357 : 1810-1820.
 
P.213 掲載の参考文献
1) Schwaibold HE, Sivalingam S, May F, et al. : The value of a second transurethral resection for T1 bladder cancer. BJU Int. 2006 ; 97 (6) : 1199-1201.
PubMed
2) Sivalingam S, Probert JL, Schwaibold H. The role of repeat transurethral resection in the management of high-risk superficial transitional cell bladder cancer. BJU Int. 2005 ; 96 (6) : 759-762.
PubMed
3) Jakse G, Algaba F, Malmstrom PU, et al. : A second-look TUR in T1 transitional cell carcinoma : why?. Eur Urol. 2004 ; 45 (5) : 539-546.
PubMed
4) Miladi M, Peyromaure M, Zerbib M, et al. : The value of a second transurethral resection in evaluating patients with bladder tumours. Eur Urol.2003 ; 43 (3) : 241-245.
PubMed
5) Herr HW : The value of a second transurethral resection in evaluating patients with bladder tumors. J Urol. 1999 ; 162 (1) : 74-76.
PubMed
6) 日本泌尿器科学会編集 : 膀胱癌診療ガイドライン 2015年版. 医学図書出版, 2015.
 
7) Impact of routine second transurethral resection on the long-term outcome of patients with newly diagnosed pT1 urothelial carcinoma with respect to recurrence, progression rate, and disease-specific survival : a Prospective randomised clinical trial. Eur Urol. 2010 ; 58 (2) : 185-190.
 

第16章 感染管理

P.217 掲載の参考文献
1) 日本環境感染学会 JHAIS委員会 医療器具関連感染サーベイランス 2009年4月～2017年12月データサマリー CLABSI_CAUTI_VAP. http://www.kankyokansen.org/uploads/uploads/files/jsipc/jhais_device-%20CLABSI_CAUTI_VAP.pdf (2018. 08. 01 available)
 
2) Centers for Disease Control and Prevention : Guidelines for the Prevention of Intravascular Catheter-Related Infections, 2011. https://www.cdc.gov/infectioncontrol/guidelines/bsi/recommendations.html (2018. 08. 01 available)
 
3) Umscheid CA, Mitchell MD, Doshi JA, et al. : Estimating the proportion of healthcare-associated infections that are reasonably preventable and the related mortality and costs. Infect Control Hosp Epidemiol. 2011 ; 32 (2) : 101-114.
 
P.218 掲載の参考文献
1) 日本環境感染学会 JHAIS委員会 医療器具関連感染サーベイランス 2009年4月～2017年12月データサマリー CLABSI_CAUTI_VAP. http://www.kankyokansen.org/uploads/uploads/files/jsipc/jhais_device-%20CLABSI_CAUTI_VAP.pdf (2018. 08. 10 available)
 
2) Saint S, Chenoweth CE : Biofilms and catheter-associated urinary tract infections. Infect Dis Clin North Am. 2003 ; 17 (2) : 411-432.
PubMed
3) Rutala WA, et al. : Incidence of catheter-associated and non-catheter-associated urinary tract infections in a healthcare system. Infect Control Hosp Epidemiol. 2011 ; 32 (8) : 822-823.
 
4) Warren JW, Platt R, Thomas RJ, et al. : Antibiotic irrigation and catheter-associated urinary-tract infections. N Engl J Med. 1978 ; 299 (11) : 570-573.
PubMed
5) Haley RW, Hooton TM, Culver DH, et al. : Nosocomial infections in U. S. hospitals, 1975-1976 : estimated frequency by selected characteristics of patients. Am J Med. 1981 ; 70 (4) : 947-959.
PubMed
6) Tambyah PA, Maki DG : Catheter-associated urinary tract infection is rarely symptomatic : a prospective study of 1,497 catheterized patients. Arch Intern Med. 2000 ; 160 (5) : 678-682.
PubMed
7) Saint S : Clinical and economic consequences of nosocomial catheter-related bacteriuria. Am J Infect Control. 2000 ; 28 (1) : 68-75.
PubMed
8) Leuck AM, Wright D, Ellingson L, et al. : Complications of Foley catheters--is infection the greatest risk? J Urol. 2012 ; 187 (5) : 1662-1666.
 
9) Umscheid CA, Mitchell MD, Doshi JA, et al. : Estimating the proportion of healthcare-associated infections that are reasonably preventable and the related mortality and costs. Infect Control Hosp Epidemiol. 2011 ; 32 (2) : 101-114.
 
10) Agency for Healthcare Research and Quality. Appendix K. Infographic Poster on CAUTI Prevention. Content last reviewed October 2015. http://www.ahrq.gov/professionals/quality-patient-safety/hais/cauti-tools/impl-guide/implementation-guide-appendix-k.html (2018. 08. 10 available)
 
P.221 掲載の参考文献
1) 日本環境感染学会 JHAIS委員会 医療器具関連感染サーベイランス 2016年7月～2017年12月データサマリー VAE. http://www.kankyokansen.org/uploads/uploads/files/jsipc/jhais_device-VAE.pdf (2018. 08. 10 available)
 
2) Safdar N, Dezfulian C, Collard HR, et al. : Clinical and economic consequences of ventilator-associated pneumonia : a systematic review. Crit Care Med. 2005 ; 33 (10) : 2184-2193.
PubMed
3) 日本集中治療医学会 ICU機能評価委員会 : 人工呼吸関連肺炎予防バンドル2010改訂版 (略 : VAPバンドル). http://www.jsicm.org/pdf/2010VAP.pdf (2018. 08. 10 available)
 
4) 日本集中治療医学会, 日本呼吸療法学会, 日本クリティカルケア看護学会 : 人工呼吸器離脱に関する3学会合同プロトコル. https://www.jsicm.org/pdf/kokyuki_ridatsu1503b.pdf (2018. 08. 10 available)
 
P.223 掲載の参考文献
1) Cosgrove SE, Sakoulas G, Perencevich EN, et al.:Comparison of mortality associated with methicillin-resistant and methicillin-susceptible Staphylococcus aureus bacteremia : a meta-analysis. Clin Infect Dis. 2003 ; 36 (1) : 53-59.
PubMed
2) Cosgrove SE, Qi Y, Kaye KS, et al. : The impact of methicillin resistance in Staphylococcus aureus bacteremia on patient outcomes : mortality, length of stay, and hospital charges. Infect Control Hosp Epidemiol. 2005 ; 26 (2) : 166-174.
PubMed
3) Nelson RE, Slayton RB, Stevens VW, et al. : Attributable Mortality of Healthcare-Associated Infections Due to Multidrug-Resistant Gram-Negative Bacteria and Methicillin-Resistant Staphylococcus Aureus. Infect Control Hosp Epidemiol. 2017 ; 38 (7) : 848-856.
PubMed
4) Calfee DP, Salgado CD, Milstone AM, et al. : Strategies to prevent methicillinresistant Staphylococcus aureus transmission and infection in acute care hospitals : 2014 update. Infect Control Hosp Epidemiol. 2014 ; 35 (7) : 772-796.
PubMed
P.224 掲載の参考文献
1) National Healthcare Safety Network (NHSN). Surveillance for C. difficile, MRSA, and other Drug-resistant Infections. Multidrug-Resistant Organism & Clostridium difficile infection (MDRO/CDI) Module. https://www.cdc.gov/nhsn/pdfs/pscmanual/12pscmdro_cdadcurrent.pdf (2017. 10. 19 available)
 
2) Dubberke ER, Carling P, Carrico R, et al. : Strategies to prevent Clostridium difficile infections in acute care hospitals : 2014 Update. Infect Control Hosp Epidemiol. 2014 ; 35 (6) : 628-645.
PubMed
P.226 掲載の参考文献
1) Centers for Disease Control and Prevention : Guideline for Hand Hygiene in Health-Care Settings, 2002. MMWR 2002 ; 51 : RR-16. http://www.cdc.gov/handhygiene/guidelines.html (2017. 07. 03 available)
 
2) WHO : WHO Guidelines on Hand Hygiene in Health Care. http://www.who.int/gpsc/5may/tools/9789241597906/en/ (2017. 07. 03 available)
 
3) Zingg W, Holmes A, Dettenkofer M, et al. : Hospital organisation, management, and structure for prevention of health-care-associated infection : a systematic review and expert consensus. Lancet Infect Dis. 2015 ; 15 (2) : 212-224.
PubMed
P.231 掲載の参考文献
1) The Society for Hospital Epidemiology of America, The Association for Practitioners in Infection Control, The Centers for Disease Control, The Surgical Infection Society. Consensus paper on the surveillance of surgical wound infections. Infect Control Hosp Epidemiol. 1992 ; 13 (10) : 599-605.
 
2) Boyce JM, Potter-Bynoe G, Dziobek L : Hospital reimbursement patterns among patients with surgical wound infections following open heart surgery. Infect Control Hosp Epidemiol. 1990 ; 11 (2) : 89-93.
PubMed
3) Poulsen KB, Bremmelgaard A, Sorensen AI, et al. : Estimated costs of postoperative wound infections. A case-control study of marginal hospital and social security costs. Epidemiol Infect. 1994 ; 113 (2) : 283-295.
PubMed
4) Umscheid CA, Mitchell MD, Doshi JA, et al. : Estimating the proportion of healthcare-associated infections that are reasonably preventable and the related mortality and costs. Infect Control Hosp Epidemiol. 2011 ; 32 (2) : 101-114.
 
5) Allegranzi B, Bischoff P, de Jonge S, et al. : New WHO recommendations on preoperative measures for surgical site infection prevention : an evidencebased global perspective. Lancet Infect Dis. 2016 ; 16 (12) : e276-287.
PubMed
6) Berrios-Torres SI, Umscheid CA, Bratzler DW, et al. : Centers for Disease Control and Prevention Guideline for the Prevention of Surgical Site Infection, 2017. JAMA Surg. 2017;152 (8) : 784-791.
PubMed
7) Ban KA, Minei JP, Laronga C, et al. : American College of Surgeons and Surgical Infection Society : Surgical Site Infection Guidelines, 2016 Update. J Am Coll Surg. 2017 ; 224 (1) : 59-74.
 
8) 厚生労働省 院内感染対策サーベイランス手術部位感染部門 公開情報 2016年年報 https://janis.mhlw.go.jp/report/ssi.html (2018. 08. 01 available)
 

書評

最近チェックした商品履歴

Loading...